{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:33:41Z","timestamp":1767108821713},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00436-023-07981-6","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T07:01:41Z","timestamp":1695884501000},"page":"2917-2931","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis"],"prefix":"10.1007","volume":"122","author":[{"given":"Marcelo M.","family":"Jesus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danniele L.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breno L.","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel J.L.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela A.G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel S.","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexsandro S.","family":"Galdino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise U.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"7981_CR1","doi-asserted-by":"publisher","first-page":"3192960","DOI":"10.1155\/2021\/3192960","volume":"2021","author":"GG Almeida","year":"2021","unstructured":"Almeida GG, Coura FM, Barbieri JM, Moura ACJ, Paes-Leme FO, Costa-Val AP (2021) FML\/QuilA-Vaccinated Dogs Naturally Infected with Leishmania infantum: Serum Cytokines, Clinicopathological Profile, and Parasitological Parameters. Biomed Res Int 2021:3192960. https:\/\/doi.org\/10.1155\/2021\/3192960","journal-title":"Biomed Res Int"},{"key":"7981_CR2","doi-asserted-by":"publisher","first-page":"e21755","DOI":"10.1096\/fj.202002356RR","volume":"35","author":"M Asad","year":"2021","unstructured":"Asad M, Sabur A, Kamran M, Shadab M, Das S, Ali N (2021) Effector functions of Th17 cells are regulated by IL-35 and TGF-\u03b2 in visceral leishmaniasis. FASEB J 35:e21755","journal-title":"FASEB J"},{"key":"7981_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3389\/fimmu.2019.00616","volume":"10","author":"M Asad","year":"2019","unstructured":"Asad M, Sabur A, Shadab M, Das S, Kamran M, Didwania N, Ali N (2019) EB1-3 chain of IL-35 along with TGF-\u03b2 synergistically regulate anti-leishmanial immunity. Front Immunol 10:616","journal-title":"Front Immunol"},{"key":"7981_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.trstmh.2007.01.005","volume":"101","author":"RB Azeredo-Coutinho","year":"2007","unstructured":"Azeredo-Coutinho RB, Concei\u00e7\u00e3o-Silva F, Schubach A, Cupolillo E, Quintella LP, Madeira MF, Pacheco RS, Valete-Rosalino CM, Mendon\u00e7a SC (2007) First report of diffuse cutaneous leishmaniasis and Leishmania amazonensis infection in Rio de Janeiro State, Brazil. Trans R Soc Trop Med Hyg 101:735\u2013737","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"7981_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cellimm.2016.07.004","volume":"309","author":"A Banerjee","year":"2016","unstructured":"Banerjee A, Bhattacharya P, Joshi AB, Ismail N, Dey R, Nakhasi HL (2016) Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines. Cell Immunol 309:37\u201341","journal-title":"Cell Immunol"},{"issue":"5","key":"7981_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4269\/ajtmh.1991.44.536","volume":"44","author":"A Barral","year":"1991","unstructured":"Barral A, Pedral-Sampaio D, Grimaldi J\u00fanior G, Momen H, McMahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badaro R, Barral-Netto M, Carvalho EM, Johnson WD Jr (1991) Leishmaniasis in Bahia, Brazil: evidence that Leishmaniaamazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44(5):536\u201346. https:\/\/doi.org\/10.4269\/ajtmh.1991.44.536","journal-title":"Am J Trop Med Hyg"},{"key":"7981_CR7","doi-asserted-by":"publisher","first-page":"2145386","DOI":"10.1155\/2017\/2145386","volume":"2017","author":"AG Bayih","year":"2017","unstructured":"Bayih AG, Daifalla NS, Gedamu L (2017) Immune response and protective efficacy of a heterologous DNA-protein immunization with Leishmania superoxide dismutase B1. Biomed Res Int 2017:2145386","journal-title":"Biomed Res Int"},{"key":"7981_CR8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/17425247.2018.1529756","volume":"15","author":"AM Bodratti","year":"2018","unstructured":"Bodratti AM, Alexandridis P (2018) Amphiphilic block copolymers in drug delivery: advances in formulation structure and performance. Expert Opin Drug Deliv 15:1085\u20131104","journal-title":"Expert Opin Drug Deliv"},{"key":"7981_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/vaccines8020252","volume":"8","author":"RCF Brito","year":"2020","unstructured":"Brito RCF, Ruiz JC, Cardoso JMO, Ostolin T, Reis LES, Mathias FAS, Aguiar-Soares RDO, Roatt BM, Corr\u00eaa-Oliveira R, Resende DM, Reis AB (2020) Chimeric vaccines designed by immunoinformatics-activated polyfunctional and memory T cells that trigger protection against experimental visceral leishmaniasis. Vaccines (Basel) 8:252","journal-title":"Vaccines (Basel)"},{"key":"7981_CR10","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","volume":"71","author":"EAF Coelho","year":"2003","unstructured":"Coelho EAF, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP (2003) Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun 71:3988\u20133994","journal-title":"Infect Immun"},{"key":"7981_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0001430","volume":"6","author":"VTS Coelho","year":"2012","unstructured":"Coelho VTS, Oliveira JS, Valadares DG, Ch\u00e1vez-Fumagalli MA, Duarte MC, Lage PS, Soto M, Santoro MM, Tavares CA, Fernandes AP, Coelho EA (2012) Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach. PLoS Negl Trop Dis 6:1\u201310","journal-title":"PLoS Negl Trop Dis"},{"key":"7981_CR12","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.vaccine.2003.11.064","volume":"22","author":"CM Coeshott","year":"2004","unstructured":"Coeshott CM, Smithson SL, Verderber E, Samaniego A, Blonder JM, Rosenthal GJ (2004) Westerink MA. Pluronic F127-based systemic vaccine delivery systems. Vaccine 22:2396\u20132405","journal-title":"Vaccine"},{"key":"7981_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11:1093\u20131101","journal-title":"Nat Immunol"},{"key":"7981_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","volume":"65","author":"MC Duarte","year":"2016","unstructured":"Duarte MC, Lage LM, Lage DP, Martins VT, Carvalho AM, Roatt BM, Menezes-Souza D, Tavares CA, Alves RJ, Barichello JM, Coelho EA (2016) Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system. Parasitol Int 65:728\u2013736","journal-title":"Parasitol Int"},{"key":"7981_CR15","doi-asserted-by":"publisher","first-page":"2496713","DOI":"10.1155\/2020\/2496713","volume":"2020","author":"T Dubie","year":"2020","unstructured":"Dubie T, Mohammed Y (2020) Review on the role of host immune response in protection and immunopathogenesis during cutaneous leishmaniasis infection. J Immunol Res 2020:2496713","journal-title":"J Immunol Res"},{"key":"7981_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/infdis\/jiy510","volume":"219","author":"WO Dutra","year":"2019","unstructured":"Dutra WO, Barbosa DF, Souza PEA, Morgan D, Poetker S, Guimar\u00e3es LH, Bacelar O, Gollob KJ, Carvalho EM (2019) A Th2-type response is associated with exuberant lesions in pregnant women infected with Leishmania braziliensis. J Infect Dis 219:480\u2013488","journal-title":"J Infect Dis"},{"key":"7981_CR17","doi-asserted-by":"publisher","first-page":"156143","DOI":"10.1016\/j.cyto.2023.156143","volume":"164","author":"CS Freitas","year":"2023","unstructured":"Freitas CS, Lage DP, Machado AS, Vale DL, Martins VT, Cardoso JMO, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Ramos FF, Ludolf F, Pereira IAG, Bandeira RS, Fujiwara RT, Bueno LL, Roatt BM, Ch\u00e1vez-Fumagalli MA, Coelho EAF (2023) Exploring drug repositioning for leishmaniasis treatment: ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis. Cytokine 164:156143","journal-title":"Cytokine"},{"key":"7981_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/meth.2001.1261","volume":"25","author":"A Giulietti","year":"2001","unstructured":"Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25:386\u2013401","journal-title":"Methods"},{"key":"7981_CR19","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","volume":"25","author":"RC Giunchetti","year":"2007","unstructured":"Giunchetti RC, Corr\u00eaa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Roatt BM, de Oliveira Aguiar-Soares RD, de Souza JV, das Dores Moreira N, Malaquias LC, Castro LL M e, de Lana M, Reis AB (2007) Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs. Vaccine 25:7674\u20137686","journal-title":"Vaccine"},{"key":"7981_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1128\/CMR.6.3.230","volume":"6","author":"G Grimaldi Jr","year":"1993","unstructured":"Grimaldi G Jr, Tesh RB (1993) Leishmaniasis of the New World: current concepts and implications for future research. Clin Microbiol Rev 6:230\u2013250","journal-title":"Clin Microbiol Rev"},{"key":"7981_CR21","first-page":"281","volume":"15","author":"M Hojatizade","year":"2018","unstructured":"Hojatizade M, Soleymani M, Tafaghodi M, Badiee A, Chavoshian O, Jaafari MR (2018) Chitosan nanoparticles loaded with whole and soluble Leishmania antigens, and evaluation of their immunogenecity in a mouse model of leishmaniasis. Iran J Immunol 15:281\u2013293","journal-title":"Iran J Immunol"},{"key":"7981_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.exppara.2015.03.027","volume":"153","author":"NC Jesus-Pereira","year":"2015","unstructured":"Jesus-Pereira NC, R\u00e9gis WC, Costa LE, Oliveira JS, Silva AG, Martins VT, Duarte MC, Souza JR, Lage PS, Schneider MS, Melo MN, Soto M, Soares SA, Tavares CA, Ch\u00e1vez-Fumagalli MA, Coelho EA (2015) Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis. Exp Parasitol 153:180\u2013190","journal-title":"Exp Parasitol"},{"key":"7981_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/ph16030334","volume":"16","author":"C Koger-Pease","year":"2023","unstructured":"Koger-Pease C, Perera DJ, Ndao M (2023) Recent advances in the development of adenovirus-vectored vaccines for parasitic infections. Pharmaceuticals (Basel) 16:334","journal-title":"Pharmaceuticals (Basel)"},{"key":"7981_CR24","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1016\/j.vaccine.2008.08.021","volume":"26","author":"S Kumari","year":"2008","unstructured":"Kumari S, Samant M, Misra P, Khare P, Sisodia B, Shasany AK, Dube A (2008) Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis. Vaccine 26:5700\u20135711","journal-title":"Vaccine"},{"key":"7981_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molimm.2023.01.011","volume":"155","author":"DP Lage","year":"2023","unstructured":"Lage DP, Machado AS, Freitas CS, Vale DL, Linhares FP, Cardoso JMO, Oliveira-da-Silva JA, Ramos FF, Pereira IAG, Ludolf F, Tavares GSV, Bandeira RS, Oliveira JS, Menezes-Souza D, Duarte MC, Galdino AS, Christodoulides M, Ch\u00e1vez-Fumagalli MA, Roatt BM et al (2023) Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasis. Mol Immunol 155:79\u201390","journal-title":"Mol Immunol"},{"key":"7981_CR26","doi-asserted-by":"publisher","first-page":"155865","DOI":"10.1016\/j.cyto.2022.155865","volume":"153","author":"DP Lage","year":"2022","unstructured":"Lage DP, Machado AS, Vale DL, Freitas CS, Linhares FP, Cardoso JMO, Pereira IAG, Ramos FF, Tavares GSV, Ludolf F, Oliveira-da-Silva JA, Bandeira RS, Silva AM, Sim\u00f5es LC, Reis TAR, Oliveira JS, Christodoulides M, Ch\u00e1vez-Fumagalli MA, Roatt BM et al (2022) Recombinant guanosine-5\u2019-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection. Cytokine 153:155865","journal-title":"Cytokine"},{"key":"7981_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/vaccines8020289","volume":"8","author":"DP Lage","year":"2020","unstructured":"Lage DP, Ribeiro PAF, Dias DS, Mendon\u00e7a DVC, Ramos FF, Carvalho LM, Steiner BT, Tavares GSV, Martins VT, Machado AS, Oliveira-da-Silva JA, Santos TTO, Freitas CS, Oliveira JS, Roatt BM, Machado-de-\u00c1vila RA, Humbert MV, Christodoulides M, Coelho EAF (2020) Liposomal formulation of ChimeraT, a multiple T-cell epitope-containing recombinant protein, is a candidate vaccine for human visceral leishmaniasis. Vaccines (Basel) 8:289","journal-title":"Vaccines (Basel)"},{"key":"7981_CR28","doi-asserted-by":"publisher","first-page":"e12921","DOI":"10.1111\/pim.12921","volume":"44","author":"AS Machado","year":"2022","unstructured":"Machado AS, Lage DP, Vale DL, Freitas CS, Linhares FP, Cardoso JMO, Oliveira-da-Silva JA, Pereira IAG, Ramos FF, Tavares GSV, Ludolf F, Bandeira RS, Maia LGN, Menezes-Souza D, Duarte MC, Ch\u00e1vez-Fumagalli MA, Roatt BM, Christodoulides M, Martins VT, Coelho EAF (2022) Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis. Parasite Immunol 44:e12921","journal-title":"Parasite Immunol"},{"key":"7981_CR29","doi-asserted-by":"publisher","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","volume":"7","author":"VT Martins","year":"2013","unstructured":"Martins VT, Ch\u00e1vez-Fumagalli MA, Costa LE, Canavaci AM, Martins AM, Lage PS, Lage DP, Duarte MC, Valadares DG, Magalh\u00e3es RD, Ribeiro TG, Nagem RA, DaRocha WD, R\u00e9gis WC, Soto M, Coelho EA, Fernandes AP, Tavares CA (2013) Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis. PLoS Negl Trop Dis 7:e2148","journal-title":"PLoS Negl Trop Dis"},{"key":"7981_CR30","doi-asserted-by":"publisher","first-page":"155297","DOI":"10.1016\/j.cyto.2020.155297","volume":"145","author":"A Mirzaei","year":"2021","unstructured":"Mirzaei A, Maleki M, Masoumi E, Maspi N (2021) A historical review of the role of cytokines involved in leishmaniasis. Cytokine 145:155297","journal-title":"Cytokine"},{"key":"7981_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.pt.2015.08.001","volume":"31","author":"R Olekhnovitch","year":"2015","unstructured":"Olekhnovitch R, Bousso P (2015) Induction, propagation, and activity of host nitric oxide: lessons from Leishmania infection. Trends Parasitol 31:653\u2013664","journal-title":"Trends Parasitol"},{"key":"7981_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-9292-6-5","volume":"6","author":"JP Oliveira","year":"2007","unstructured":"Oliveira JP, Fernandes F, Cruz AK, Trombela V, Monteiro E, Camargo AA, Barral A, Oliveira CI (2007) Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping. Kinetoplastid Biol Dis 6:5","journal-title":"Kinetoplastid Biol Dis"},{"key":"7981_CR33","doi-asserted-by":"publisher","first-page":"104283","DOI":"10.1016\/j.micpath.2020.104283","volume":"147","author":"JA Oliveira-da-Silva","year":"2020","unstructured":"Oliveira-da-Silva JA, Machado AS, Tavares GSV, Ramos FF, Lage DP, Ludolf F, Steiner BT, Reis TAR, Santos TTO, Costa LE, Bandeira RS, Martins VT, Galvani NC, Chaves AT, Oliveira JS, Ch\u00e1vez-Fumagalli MA, Tupinamb\u00e1s U, de Magalh\u00e3es-Soares DF, Silveira JAG et al (2020) Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis. Microb Pathog 147:104283","journal-title":"Microb Pathog"},{"key":"7981_CR34","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","volume":"26","author":"CB Palatnik-de-Sousa","year":"2008","unstructured":"Palatnik-de-Sousa CB (2008) Vaccines for leishmaniasis in the fore coming 25 years. Vaccine 26:1709\u20131724","journal-title":"Vaccine"},{"key":"7981_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","volume":"62","author":"V Peruhype-Magalh\u00e3es","year":"2005","unstructured":"Peruhype-Magalh\u00e3es V, Martins-Filho OA, Prata A, Silva LA, Rabello A, Teixeira-Carvalho A, Figueiredo RM, Guimar\u00e3es-Carvalho SF, Ferrari TC, Correa-Oliveira R (2005) Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. Scand J Immunol 62:487\u2013495","journal-title":"Scand J Immunol"},{"key":"7981_CR36","doi-asserted-by":"publisher","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","volume":"11","author":"A Ponte-Sucre","year":"2017","unstructured":"Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, L\u00f3pez-V\u00e9lez R, Garc\u00eda-Hern\u00e1ndez R, Pountain AW, Mwenechanya R, Papadopoulou B (2017) Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Negl Trop Dis 11:e0006052","journal-title":"PLoS Negl Trop Dis"},{"key":"7981_CR37","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00436-020-06752-x","volume":"119","author":"PAF Ribeiro","year":"2020","unstructured":"Ribeiro PAF, Dias DS, Lage DP, Mendon\u00e7a DVC, Vale DL, Ramos FF, Carvalho LM, Carvalho AMRS, Steiner BT, Roque MC, Oliveira-da-Silva JA, Oliveira JS, Tavares GSV, Martins VT, Ch\u00e1vez-Fumagalli MA, Roatt BM, Moreira RLF, Menezes-Souza D, Duarte MC et al (2020) Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells. Parasitol Res 119:2609\u20132622","journal-title":"Parasitol Res"},{"key":"7981_CR38","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00436-021-07139-2","volume":"120","author":"S Sasidharan","year":"2021","unstructured":"Sasidharan S, Saudagar P (2021) Leishmaniasis: where are we and where are we heading? Parasitol Res 120:1541\u20131554","journal-title":"Parasitol Res"},{"key":"7981_CR39","doi-asserted-by":"publisher","first-page":"e1003476","DOI":"10.1371\/journal.ppat.1003476","volume":"9","author":"T Schwarz","year":"2013","unstructured":"Schwarz T, Remer KA, Nahrendorf W, Masic A, Siewe L, M\u00fcller W, Roers A, Moll H (2013) T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine. PLoS Pathog 9:e1003476","journal-title":"PLoS Pathog"},{"issue":"12","key":"7981_CR40","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1080\/21645515.2020.1833579","volume":"16","author":"R Sharma","year":"2020","unstructured":"Sharma R, Palanisamy A, Dhama K, Mal G, Singh B, Singh KP (2020) Exploring the possible use of saponin adjuvants in COVID-19 vaccine. Hum Vaccin Immunother 16(12):2944\u20132953. https:\/\/doi.org\/10.1080\/21645515.2020.1833579","journal-title":"Hum Vaccin Immunother"},{"key":"7981_CR41","doi-asserted-by":"publisher","first-page":"106018","DOI":"10.1016\/j.actatropica.2021.106018","volume":"221","author":"TF Silva","year":"2021","unstructured":"Silva TF, Tomiotto-Pellissier F, Pasquali AKS, Pinto-Ferreira F, Pavanelli WR, Conchon-Costa I, Navarro IT, Caldart ET (2021) Phenotypical and genotypical differences among Leishmania (Leishmania) amazonensis isolates that caused different clinical frames in humans and dogs: a systematic review. Acta Trop 221:106018","journal-title":"Acta Trop"},{"key":"7981_CR42","doi-asserted-by":"publisher","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","volume":"6","author":"OP Singh","year":"2012","unstructured":"Singh OP, Stober CB, Singh AK, Blackwell JM, Sundar S (2012) Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis. PLoS Negl Trop Dis 6:e1874","journal-title":"PLoS Negl Trop Dis"},{"key":"7981_CR43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40291-018-0343-y","volume":"22","author":"S Sundar","year":"2018","unstructured":"Sundar S, Singh OP (2018) Molecular diagnosis of visceral leishmaniasis. Mol Diagn Ther 22:443\u2013457","journal-title":"Mol Diagn Ther"},{"key":"7981_CR44","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.imbio.2015.05.014","volume":"220","author":"A Thakur","year":"2015","unstructured":"Thakur A, Kaur H, Kaur S (2015) Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice. Immunobiology 220:1031\u20131038","journal-title":"Immunobiology"},{"key":"7981_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","volume":"44","author":"ME Turnis","year":"2016","unstructured":"Turnis ME, Sawant DV, Szymczak-Workman AL, Andrews LP, Delgoffe GM, Yano H, Beres AJ, Vogel P, Workman CJ, Vignali DAA (2016) Interleukin-35 limits anti-tumor immunity. Immunity 44:316\u2013329","journal-title":"Immunity"},{"key":"7981_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.diagmicrobio.2019.04.015","volume":"95","author":"DL Vale","year":"2019","unstructured":"Vale DL, Dias DS, Machado AS, Ribeiro PAF, Lage DP, Costa LE, Steiner BT, Tavares GSV, Ramos FF, Mart\u00ednez-Rodrigo A, Ch\u00e1vez-Fumagalli MA, Caligiorne RB, de Magalh\u00e3es-Soares DF, Silveira JAG, Machado-de-\u00c1vila RA, Teixeira AL, Coelho EAF (2019) Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls. Diagn Microbiol Infect Dis 95:134\u2013143","journal-title":"Diagn Microbiol Infect Dis"},{"key":"7981_CR47","doi-asserted-by":"publisher","first-page":"104592","DOI":"10.1016\/j.cellimm.2022.104592","volume":"380","author":"DL Valentim","year":"2022","unstructured":"Valentim DL, Ostolin TP, Gusm\u00e3o MR, Mathias FAS, Cardoso JMO, Roatt BM, Aguiar-Soares RDO, Ruiz JC, Resende DM, Brito RCF, Reis AB (2022) A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis. Cell Immunol 380:104592","journal-title":"Cell Immunol"},{"key":"7981_CR48","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DA Vignali","year":"2012","unstructured":"Vignali DA, Kuchroo VK (2012) IL-12 family cytokines: immunological playmakers. Nat Immunol 13:722\u2013728","journal-title":"Nat Immunol"},{"key":"7981_CR49","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1080\/14760584.2021.1969231","volume":"20","author":"G Volpedo","year":"2021","unstructured":"Volpedo G, Huston RH, Holcomb EA, Pacheco-Fernandez T, Gannavaram S, Bhattacharya P, Nakhasi HL, Satoskar AR (2021) From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection. Expert Rev Vaccines 20:1431\u20131446","journal-title":"Expert Rev Vaccines"},{"key":"7981_CR50","doi-asserted-by":"publisher","first-page":"e0270722","DOI":"10.1371\/journal.pone.0270722","volume":"18","author":"H Wijesooriya","year":"2023","unstructured":"Wijesooriya H, Samaranayake N, Karunaweera ND (2023) Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani. PLoS One 18:e0270722","journal-title":"PLoS One"},{"key":"7981_CR51","unstructured":"World Health Organisation (2023).\u00a0http:\/\/www.who.int\/topics\/leishmaniasis\/en\/ Available online: Accessed 30 Mar 2023"},{"key":"7981_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1751-2980.12218","volume":"16","author":"XG Xiang","year":"2015","unstructured":"Xiang XG, Xie Q (2015) IL-35: a potential therapeutic target for controlling hepatitis B virus infection. J Dig Dis 16:1\u20136","journal-title":"J Dig Dis"},{"key":"7981_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molimm.2020.08.006","volume":"127","author":"NE Zorgi","year":"2020","unstructured":"Zorgi NE, Arruda LV, Paladine I, Roque GAS, Ara\u00fajo TF, Brocchi M, Barral M, Sanchiz \u00c1, Requena JM, Ab\u00e1nades DR, Giorgio S (2020) Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis. Mol Immunol 127:95\u2013106","journal-title":"Mol Immunol"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-023-07981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-023-07981-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-023-07981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T09:06:33Z","timestamp":1700730393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-023-07981-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["7981"],"URL":"https:\/\/doi.org\/10.1007\/s00436-023-07981-6","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"20 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Committee on the Ethical Handling of Research Animals of UFMG approved the study with protocol number 144\/2020. In addition, the project was approved by the Ethics Committee on Human Research of University, with protocol number CAAE\u201332343114.9.0000.5149. A consent form was explained to and signed by all the participants, which accepted to participate and consented to publish their laboratorial results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}